| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutathione binding | 1.11e-05 | 18 | 160 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 1.74e-05 | 20 | 160 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | kinase regulator activity | ERBB3 CCNP ATG14 MBIP MADD EGFR SOCS1 INCA1 GCN1 HYAL2 HSP90AB1 | 3.64e-05 | 305 | 160 | 11 | GO:0019207 |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 4.69e-05 | 259 | 160 | 10 | GO:0019887 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 5.81e-05 | 10 | 160 | 3 | GO:0043225 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 8.07e-05 | 29 | 160 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.05e-04 | 12 | 160 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.72e-04 | 14 | 160 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | 3.79e-04 | 4 | 160 | 2 | GO:0050510 | |
| GeneOntologyMolecularFunction | receptor ligand inhibitor activity | 3.79e-04 | 4 | 160 | 2 | GO:0141069 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 VWA8 KIF26A MYO9A SMCHD1 ABCC5 ABCC9 MCM6 MSH5 ATAD2 HELZ MACF1 ABCC10 HSP90AB1 | 4.36e-04 | 614 | 160 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.35e-04 | 49 | 160 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 VWA8 KIF26A SMCHD1 ABCC5 ABCC9 MCM6 ATAD2 MACF1 ABCC10 HSP90AB1 | 8.78e-04 | 441 | 160 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 9.37e-04 | 6 | 160 | 2 | GO:0047238 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ERBB3 ABCA2 PSD2 TRIO MYO9A DOCK8 RANBP3 CCNP ATG14 MBIP TBC1D17 MADD VPS9D1 EGFR SIPA1L1 PPP1R16B SOCS1 ELMOD3 HERC1 INCA1 GCN1 HYAL2 HSP90AB1 | 9.45e-04 | 1418 | 160 | 23 | GO:0030234 |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 1.72e-06 | 4 | 157 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 6.58e-06 | 217 | 157 | 10 | GO:0046474 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | ABCA2 CWH43 GPAA1 CHAT ATG14 PGAP4 EFR3A PIGA CHPT1 PIK3CD SOCS1 | 6.81e-06 | 268 | 157 | 11 | GO:0008654 |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 7.81e-06 | 132 | 157 | 8 | GO:0006661 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 7.81e-06 | 132 | 157 | 8 | GO:0006022 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 1.15e-05 | 100 | 157 | 7 | GO:1903510 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 2.49e-05 | 76 | 157 | 6 | GO:0006024 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 3.34e-05 | 80 | 157 | 6 | GO:0006023 | |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | CWH43 GPAA1 CHAT ATG14 PGAP4 EFR3A PIGA CHPT1 PIK3CD SOCS1 PNPLA7 | 3.54e-05 | 320 | 157 | 11 | GO:0006650 |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 3.96e-05 | 121 | 157 | 7 | GO:0030203 | |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | 4.07e-05 | 268 | 157 | 10 | GO:0045017 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | ABCA2 CWH43 GPAA1 CHST14 ABCC5 PGAP4 XYLT1 TMEM260 VPS9D1 JAK3 FCSK PIGA GAL3ST3 CHPF2 CHSY3 GALNT6 HAS3 | 4.76e-05 | 736 | 157 | 17 | GO:1901137 |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 4.87e-05 | 170 | 157 | 8 | GO:0046488 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | ABCA2 CWH43 GPAA1 CYP8B1 BCKDK CHAT ATG14 PGAP4 EFR3A GSTM1 GSTM2 GSTM4 PIGA CHPT1 PIK3CD GAL3ST3 TM7SF2 SOCS1 | 4.88e-05 | 813 | 157 | 18 | GO:0008610 |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | ABCA2 CWH43 GPAA1 CHAT ATG14 PGAP4 EFR3A PIGA CHPT1 PIK3CD SOCS1 PNPLA7 | 7.39e-05 | 410 | 157 | 12 | GO:0006644 |
| GeneOntologyBiologicalProcess | GPI anchor biosynthetic process | 1.11e-04 | 33 | 157 | 4 | GO:0006506 | |
| GeneOntologyBiologicalProcess | GPI anchor metabolic process | 1.41e-04 | 35 | 157 | 4 | GO:0006505 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.75e-04 | 37 | 157 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 1.95e-04 | 70 | 157 | 5 | GO:0030166 | |
| GeneOntologyBiologicalProcess | glycolipid metabolic process | 3.02e-04 | 119 | 157 | 6 | GO:0006664 | |
| GeneOntologyBiologicalProcess | liposaccharide metabolic process | 3.16e-04 | 120 | 157 | 6 | GO:1903509 | |
| GeneOntologyBiologicalProcess | glycolipid biosynthetic process | 3.85e-04 | 81 | 157 | 5 | GO:0009247 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | ABCA2 CWH43 GPAA1 CHST14 GNPTAB ABCC5 ABCC9 PGAP4 ENTPD4 XYLT1 TMEM260 VPS9D1 JAK3 FCSK PIGA GAL3ST3 CHPF2 CHSY3 GALNT6 HAS3 HYAL2 | 4.13e-04 | 1226 | 157 | 21 | GO:1901135 |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | ABCA2 CWH43 CHST14 XYLT1 TMEM260 JAK3 GAL3ST3 CHPF2 CHSY3 GALNT6 | 4.20e-04 | 357 | 157 | 10 | GO:0009101 |
| GeneOntologyBiologicalProcess | chondroitin sulfate biosynthetic process | 4.48e-04 | 20 | 157 | 3 | GO:0030206 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | CWH43 GPAA1 CHAT ATG14 PGAP4 EFR3A PIGA CHPT1 PIK3CD SOCS1 PNPLA7 | 4.58e-04 | 429 | 157 | 11 | GO:0046486 |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | ABCA2 CWH43 CHST14 GNPTAB XYLT1 TMEM260 JAK3 GAL3ST3 CHPF2 CHSY3 GALNT6 | 4.67e-04 | 430 | 157 | 11 | GO:0009100 |
| HumanPheno | Abnormal nostril morphology | DIS3L2 GPAA1 TRIO SMCHD1 GNPTAB POLRMT ABCC9 NARS2 MADD XYLT1 SNX14 PIGA PIK3CD AUTS2 LTBP1 LAS1L CPLANE1 VPS51 | 9.79e-06 | 575 | 53 | 18 | HP:0005288 |
| HumanPheno | Anteverted nares | DIS3L2 GPAA1 TRIO GNPTAB POLRMT ABCC9 NARS2 MADD XYLT1 SNX14 PIGA PIK3CD AUTS2 LTBP1 LAS1L CPLANE1 VPS51 | 2.79e-05 | 559 | 53 | 17 | HP:0000463 |
| HumanPheno | Upturned nose | DIS3L2 GPAA1 TRIO GNPTAB POLRMT ABCC9 NARS2 MADD XYLT1 SNX14 PIGA PIK3CD AUTS2 LTBP1 LAS1L CPLANE1 VPS51 | 2.79e-05 | 559 | 53 | 17 | HP:0000427 |
| Domain | GST_mu | 2.64e-08 | 5 | 161 | 4 | IPR003081 | |
| Domain | GST_N | 1.05e-06 | 22 | 161 | 5 | PF02798 | |
| Domain | GST_C | 2.54e-06 | 26 | 161 | 5 | IPR004046 | |
| Domain | GST_C | 2.54e-06 | 26 | 161 | 5 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 3.10e-06 | 27 | 161 | 5 | IPR004045 | |
| Domain | GST_CTER | 1.02e-05 | 34 | 161 | 5 | PS50405 | |
| Domain | TRP_2 | 1.23e-05 | 6 | 161 | 3 | PF08344 | |
| Domain | TRP_dom | 1.23e-05 | 6 | 161 | 3 | IPR013555 | |
| Domain | Glutathione-S-Trfase_C-like | 2.03e-05 | 39 | 161 | 5 | IPR010987 | |
| Domain | - | 2.03e-05 | 39 | 161 | 5 | 1.20.1050.10 | |
| Domain | Recep_L_domain | 2.15e-05 | 7 | 161 | 3 | PF01030 | |
| Domain | TRPC_channel | 2.15e-05 | 7 | 161 | 3 | IPR002153 | |
| Domain | Furin-like | 2.15e-05 | 7 | 161 | 3 | PF00757 | |
| Domain | Rcpt_L-dom | 2.15e-05 | 7 | 161 | 3 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 2.15e-05 | 7 | 161 | 3 | IPR006211 | |
| Domain | - | 2.15e-05 | 7 | 161 | 3 | 3.80.20.20 | |
| Domain | GST_NTER | 3.45e-05 | 22 | 161 | 4 | PS50404 | |
| Domain | Distrobrevin | 7.39e-05 | 2 | 161 | 2 | IPR017432 | |
| Domain | TRP_channel | 9.86e-05 | 11 | 161 | 3 | IPR004729 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 4.38e-04 | 4 | 161 | 2 | IPR016245 | |
| Domain | ABC_transporter_CS | 4.61e-04 | 42 | 161 | 4 | IPR017871 | |
| Domain | ZF_ZZ_2 | 4.66e-04 | 18 | 161 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.66e-04 | 18 | 161 | 3 | PS01357 | |
| Domain | ZZ | 4.66e-04 | 18 | 161 | 3 | PF00569 | |
| Domain | Furin_repeat | 4.66e-04 | 18 | 161 | 3 | IPR006212 | |
| Domain | FU | 4.66e-04 | 18 | 161 | 3 | SM00261 | |
| Domain | Znf_ZZ | 5.50e-04 | 19 | 161 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 5.50e-04 | 19 | 161 | 3 | SM00291 | |
| Domain | - | 6.43e-04 | 20 | 161 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 7.46e-04 | 21 | 161 | 3 | IPR003594 | |
| Domain | ABC_tran | 7.70e-04 | 48 | 161 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.70e-04 | 48 | 161 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 8.33e-04 | 49 | 161 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 9.00e-04 | 50 | 161 | 4 | IPR003439 | |
| Domain | - | 1.08e-03 | 6 | 161 | 2 | 3.90.1290.10 | |
| Domain | GF_recep_IV | 1.08e-03 | 6 | 161 | 2 | PF14843 | |
| Domain | GF_recep_IV | 1.08e-03 | 6 | 161 | 2 | IPR032778 | |
| Domain | EF-hand_dom_typ1 | 1.08e-03 | 6 | 161 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.08e-03 | 6 | 161 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 1.08e-03 | 6 | 161 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.08e-03 | 6 | 161 | 2 | PF09069 | |
| Domain | ABC_membrane | 1.11e-03 | 24 | 161 | 3 | PF00664 | |
| Domain | Plectin | 1.51e-03 | 7 | 161 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.51e-03 | 7 | 161 | 2 | IPR001101 | |
| Domain | PLEC | 1.51e-03 | 7 | 161 | 2 | SM00250 | |
| Domain | AAA | 1.57e-03 | 144 | 161 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.57e-03 | 144 | 161 | 6 | IPR003593 | |
| Domain | ABC_TM1F | 1.76e-03 | 28 | 161 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.76e-03 | 28 | 161 | 3 | IPR011527 | |
| Domain | Spectrin_repeat | 1.95e-03 | 29 | 161 | 3 | IPR002017 | |
| Domain | Chond_GalNAc | 2.00e-03 | 8 | 161 | 2 | IPR008428 | |
| Domain | CHGN | 2.00e-03 | 8 | 161 | 2 | PF05679 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.64e-05 | 19 | 118 | 4 | M47809 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE | 3.04e-05 | 22 | 118 | 4 | M19166 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 3.65e-05 | 23 | 118 | 4 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 4.36e-05 | 24 | 118 | 4 | M47487 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 6.57e-05 | 10 | 118 | 3 | M27330 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 7.68e-05 | 123 | 118 | 7 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 8.94e-05 | 126 | 118 | 7 | M695 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 2.23e-04 | 36 | 118 | 4 | M1443 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 2.76e-04 | 38 | 118 | 4 | MM14600 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 3.57e-04 | 17 | 118 | 3 | M666 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 3.57e-04 | 17 | 118 | 3 | MM14864 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 3.72e-04 | 41 | 118 | 4 | M48095 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.89e-04 | 44 | 118 | 4 | M11911 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 4.89e-04 | 44 | 118 | 4 | M875 | |
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 18551009 | ||
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 19856098 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ERBB3 GPAA1 STUB1 CHST14 DTNB SMCHD1 TTC27 TARS2 ENTPD4 P3H4 NARS2 S1PR5 MROH1 CHPT1 SCARA5 MACF1 LTBP1 CLINT1 ATG9A HERC1 ABCC10 | 2.37e-08 | 1061 | 161 | 21 | 33845483 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 TRIO VWA8 KIF26A GRK6 LAD1 POLRMT LMNB2 TBC1D17 MADD JAK3 GRAMD2A MROH1 CELSR3 PIK3CD XPO6 ATG9A HERC1 HAS3 GCN1 ABCC10 | 4.72e-08 | 1105 | 161 | 21 | 35748872 |
| Pubmed | TRIO DSP DTNA DTNB BCKDK TTC27 TARS2 C2CD4C MADD EFR3A GSE1 EGFR PRIM2 HELZ LTBP1 CLINT1 HERC1 MAPK11 GCN1 HSP90AB1 | 9.61e-08 | 1049 | 161 | 20 | 27880917 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 28790178 | ||
| Pubmed | Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels. | 9.74e-08 | 3 | 161 | 3 | 30755645 | |
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 9.74e-08 | 3 | 161 | 3 | 32574561 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 9452477 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 16549767 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 34199280 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8471052 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 32359120 | ||
| Pubmed | Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels. | 9.74e-08 | 3 | 161 | 3 | 28325835 | |
| Pubmed | Dual action of the Gαq-PLCβ-PI(4,5)P2 pathway on TRPC1/4 and TRPC1/5 heterotetramers. | 9.74e-08 | 3 | 161 | 3 | 30108272 | |
| Pubmed | TRIO DSP PPFIA4 LAD1 INSRR EGFR PRIM2 LRRCC1 LTBP1 GCN1 HSP90AB1 | 1.00e-07 | 284 | 161 | 11 | 29459677 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 18261457 | ||
| Pubmed | Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. | 3.88e-07 | 4 | 161 | 3 | 8317488 | |
| Pubmed | NMDA receptor-dependent synaptic activation of TRPC channels in olfactory bulb granule cells. | 3.88e-07 | 4 | 161 | 3 | 22539836 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 32110987 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 22406107 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 8373352 | ||
| Pubmed | Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. | 3.88e-07 | 4 | 161 | 3 | 19151192 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 23188715 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.77e-07 | 101 | 161 | 7 | 23382219 | |
| Pubmed | Formation of novel TRPC channels by complex subunit interactions in embryonic brain. | 9.67e-07 | 5 | 161 | 3 | 12857742 | |
| Pubmed | Enhanced capacitative calcium entry and TRPC channel gene expression in human LES smooth muscle. | 9.67e-07 | 5 | 161 | 3 | 12736151 | |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 20458742 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 11390792 | ||
| Pubmed | trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. | 1.93e-06 | 6 | 161 | 3 | 8646775 | |
| Pubmed | TRPC channels regulate Ca2+-signaling and short-term plasticity of fast glutamatergic synapses. | 1.93e-06 | 6 | 161 | 3 | 31536487 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 1530570 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 32414784 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 29373286 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 25347706 | ||
| Pubmed | CA11 ERBB3 ABCA2 STUB1 TRIO DSP GNPTAB TTC27 ABCC5 ZNF785 MADD VPS9D1 CELSR3 SIPA1L1 PPP1R16B LRRCC1 MACF1 VARS1 CRTAP HSP90AB1 | 2.27e-06 | 1285 | 161 | 20 | 35914814 | |
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 3.36e-06 | 7 | 161 | 3 | 15757897 | |
| Pubmed | Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. | 3.36e-06 | 7 | 161 | 3 | 23233529 | |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 3.36e-06 | 7 | 161 | 3 | 15336983 | |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 32350291 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 38835669 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 36257322 | ||
| Pubmed | 3.54e-06 | 193 | 161 | 8 | 19343046 | ||
| Pubmed | 4.37e-06 | 24 | 161 | 4 | 9722956 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 25471572 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 15199065 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 5.36e-06 | 8 | 161 | 3 | 12032305 | |
| Pubmed | Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. | 8.01e-06 | 9 | 161 | 3 | 14505576 | |
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 17480026 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 11290752 | ||
| Pubmed | 1.10e-05 | 30 | 161 | 4 | 20200426 | ||
| Pubmed | 1.14e-05 | 10 | 161 | 3 | 27177420 | ||
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 1.14e-05 | 10 | 161 | 3 | 18989690 | |
| Pubmed | 1.63e-05 | 33 | 161 | 4 | 19834762 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 16144838 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 2689439 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34884742 | ||
| Pubmed | Structure of human glutathione S-transferase class Mu genes. | 2.13e-05 | 2 | 161 | 2 | 2006920 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 3174634 | ||
| Pubmed | TRPC1 and TRPC5 form a novel cation channel in mammalian brain. | 2.13e-05 | 2 | 161 | 2 | 11301024 | |
| Pubmed | Distribution of TRPC1 and TRPC5 in medial temporal lobe structures of mice. | 2.13e-05 | 2 | 161 | 2 | 16044320 | |
| Pubmed | ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma. | 2.13e-05 | 2 | 161 | 2 | 20647770 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24048194 | ||
| Pubmed | TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling. | 2.13e-05 | 2 | 161 | 2 | 22451676 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 37156315 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19725137 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21968068 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 26034219 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8909248 | ||
| Pubmed | EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis. | 2.13e-05 | 2 | 161 | 2 | 27756321 | |
| Pubmed | DNA methylation is associated with altered gene expression in AMD. | 2.13e-05 | 2 | 161 | 2 | 22410570 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12486119 | ||
| Pubmed | TRPC4 forms store-operated Ca2+ channels in mouse mesangial cells. | 2.13e-05 | 2 | 161 | 2 | 15044151 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 26844548 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24399650 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21203460 | ||
| Pubmed | The Histone Demethylase NO66 Induces Glioma Cell Proliferation. | 2.13e-05 | 2 | 161 | 2 | 31704826 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23675469 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 32080212 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22457348 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23677990 | ||
| Pubmed | CHIP is a novel tumor suppressor in pancreatic cancer through targeting EGFR. | 2.13e-05 | 2 | 161 | 2 | 24722501 | |
| Pubmed | Involvement of TRPC4 and 5 Channels in Persistent Firing in Hippocampal CA1 Pyramidal Cells. | 2.13e-05 | 2 | 161 | 2 | 32033274 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 36045406 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17624425 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31092882 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 34899056 | ||
| Pubmed | Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. | 2.13e-05 | 2 | 161 | 2 | 17593972 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 27872189 | ||
| Pubmed | Genomic organization and characterization of the promoter region of murine GSTM2 gene. | 2.13e-05 | 2 | 161 | 2 | 11404019 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21690342 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30302022 | ||
| Pubmed | TRPC channels determine human keratinocyte differentiation: new insight into basal cell carcinoma. | 2.13e-05 | 2 | 161 | 2 | 17920677 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 6500576 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 28388560 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 26317356 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 15763245 | ||
| Pubmed | Cloning and expression of a novel Mu class murine glutathione transferase isoenzyme. | 2.13e-05 | 2 | 161 | 2 | 12069689 | |
| Pubmed | A novel capacitative calcium entry channel expressed in excitable cells. | 2.13e-05 | 2 | 161 | 2 | 9687496 | |
| Interaction | OR10H1 interactions | 9.94e-08 | 49 | 157 | 7 | int:OR10H1 | |
| Interaction | TRMU interactions | 3.94e-07 | 87 | 157 | 8 | int:TRMU | |
| Interaction | GSTM2 interactions | 6.37e-07 | 22 | 157 | 5 | int:GSTM2 | |
| Interaction | GSTM5 interactions | 4.53e-06 | 15 | 157 | 4 | int:GSTM5 | |
| Interaction | C1orf54 interactions | 6.58e-06 | 167 | 157 | 9 | int:C1orf54 | |
| Interaction | JAK3 interactions | 1.15e-05 | 136 | 157 | 8 | int:JAK3 | |
| Interaction | CIBAR1 interactions | 1.21e-05 | 137 | 157 | 8 | int:CIBAR1 | |
| Interaction | GPR182 interactions | ABCA2 GPAA1 TTC27 TARS2 ENTPD4 NARS2 FCSK SNX14 MROH1 CHPT1 XPO6 VPS51 GCN1 PRAME | 1.35e-05 | 455 | 157 | 14 | int:GPR182 |
| Interaction | LCK interactions | ERBB3 STUB1 TRIO DSP DTNA TARS2 EFR3A JAK3 EGFR SOCS1 MACF1 PARD3 VARS1 HSP90AB1 | 1.64e-05 | 463 | 157 | 14 | int:LCK |
| Interaction | HLA-B interactions | 1.86e-05 | 239 | 157 | 10 | int:HLA-B | |
| Interaction | MTMR9 interactions | 1.92e-05 | 71 | 157 | 6 | int:MTMR9 | |
| Interaction | SHC2 interactions | 2.29e-05 | 44 | 157 | 5 | int:SHC2 | |
| Interaction | DPEP2 interactions | 3.89e-05 | 49 | 157 | 5 | int:DPEP2 | |
| Interaction | DIRAS3 interactions | DTNA RNF19B ATG14 C2CD4C EFR3A EGFR MACF1 ELMOD3 HERC1 PARD3 | 4.08e-05 | 262 | 157 | 10 | int:DIRAS3 |
| Cytoband | 1p13.3 | 1.05e-04 | 69 | 161 | 4 | 1p13.3 | |
| Cytoband | 2p22-p21 | 3.38e-04 | 8 | 161 | 2 | 2p22-p21 | |
| GeneFamily | Glutathione S-transferases | 1.28e-05 | 25 | 106 | 4 | 567 | |
| GeneFamily | ATP binding cassette subfamily C | 5.37e-05 | 13 | 106 | 3 | 807 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.50e-04 | 18 | 106 | 3 | 91 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 2.03e-04 | 4 | 106 | 2 | 1096 | |
| GeneFamily | Transient receptor potential cation channels | 5.77e-04 | 28 | 106 | 3 | 249 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.32e-04 | 8 | 106 | 2 | 939 | |
| GeneFamily | Maestro heat like repeat containing | 1.81e-03 | 11 | 106 | 2 | 636 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN | 1.66e-08 | 104 | 161 | 9 | M8938 | |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_UP | 1.26e-05 | 49 | 161 | 5 | M25 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.63e-05 | 180 | 161 | 8 | M8239 | |
| Coexpression | OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN | 1.86e-05 | 9 | 161 | 3 | M41069 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-06 | 174 | 161 | 7 | 7565f6d1c743809807d248ab0e098a2474d9c5b9 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 176 | 161 | 7 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 176 | 161 | 7 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 177 | 161 | 7 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 177 | 161 | 7 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 179 | 161 | 7 | e520eadde4f1b7fb868dbbe94c4d62b3776c55eb | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 4.72e-06 | 183 | 161 | 7 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.44e-06 | 187 | 161 | 7 | d69f4eee0304a7db226275ab77fc9d5d2b6f3a07 | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 6.04e-06 | 190 | 161 | 7 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-06 | 191 | 161 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.25e-06 | 191 | 161 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.16e-06 | 195 | 161 | 7 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.16e-06 | 195 | 161 | 7 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.40e-06 | 196 | 161 | 7 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.40e-06 | 196 | 161 | 7 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-06 | 197 | 161 | 7 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 8.45e-06 | 200 | 161 | 7 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.45e-06 | 200 | 161 | 7 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.86e-05 | 163 | 161 | 6 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-05 | 168 | 161 | 6 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.74e-05 | 171 | 161 | 6 | 341f9f79c1ed654ab347e25dc4936f89ffdf9617 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.74e-05 | 171 | 161 | 6 | ce290930385cac35dbd21a5e91cf0f93cf3e99f8 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 172 | 161 | 6 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.12e-05 | 174 | 161 | 6 | 33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 177 | 161 | 6 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-05 | 177 | 161 | 6 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 177 | 161 | 6 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.82e-05 | 179 | 161 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 5.13e-05 | 181 | 161 | 6 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 5.29e-05 | 182 | 161 | 6 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 5.45e-05 | 183 | 161 | 6 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.45e-05 | 183 | 161 | 6 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-05 | 184 | 161 | 6 | 49eccf72725593a8fb4a529e7985a5c413b3ca6a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-05 | 184 | 161 | 6 | 41164109d9d7bb1c431220e2e85e08dc5f56856d | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-05 | 184 | 161 | 6 | bba0138c8f7e3645a688b9a4d12f6f2134ee2c08 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-05 | 184 | 161 | 6 | eaef1dcde60ba14e2c7fd699d01c225487256d82 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-05 | 184 | 161 | 6 | fa73738350654066d7f9ebf78359e20ee6cbdd98 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 5.62e-05 | 184 | 161 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 5.79e-05 | 185 | 161 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.79e-05 | 185 | 161 | 6 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.33e-05 | 188 | 161 | 6 | 8231e635706a296db6b6da1029a33bbc1b52478e | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.33e-05 | 188 | 161 | 6 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.71e-05 | 190 | 161 | 6 | 251d50a77e5118a9ad19ea01a7c7c862230ed63c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 190 | 161 | 6 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-05 | 190 | 161 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.71e-05 | 190 | 161 | 6 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 191 | 161 | 6 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 191 | 161 | 6 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.91e-05 | 191 | 161 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 191 | 161 | 6 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.91e-05 | 191 | 161 | 6 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.91e-05 | 191 | 161 | 6 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 6.91e-05 | 191 | 161 | 6 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 7.11e-05 | 192 | 161 | 6 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.11e-05 | 192 | 161 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 193 | 161 | 6 | 40eedc1490c113403bc7c12a6bdf976f4f8bca84 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-05 | 194 | 161 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 194 | 161 | 6 | f906b090f67df4cfe3498cdbb52cc0efa08e06cc | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 194 | 161 | 6 | 944cdb0403d80a10a2eea2a3516a9343dbccc32c | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 7.53e-05 | 194 | 161 | 6 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 194 | 161 | 6 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 194 | 161 | 6 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 194 | 161 | 6 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 194 | 161 | 6 | 85081d255fcc1e9854c0073321dd9f0feaa48866 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 7.53e-05 | 194 | 161 | 6 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-05 | 194 | 161 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 195 | 161 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.74e-05 | 195 | 161 | 6 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.74e-05 | 195 | 161 | 6 | fa5fc6f605deb5cae96eec14ba4000b19f877ba6 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 195 | 161 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 195 | 161 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 11.5-Distal-Epithelial-Bud_tip_progenitor|Distal / Age, Tissue, Lineage and Cell class | 7.96e-05 | 196 | 161 | 6 | 42eae265e2f2082983d8c2607c7f6a53a526d124 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 196 | 161 | 6 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 196 | 161 | 6 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-05 | 196 | 161 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-05 | 196 | 161 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 196 | 161 | 6 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.19e-05 | 197 | 161 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.19e-05 | 197 | 161 | 6 | febafd8f0f5bb9a09f496f240e6b6b5e9275669b | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.19e-05 | 197 | 161 | 6 | b0fb5774525ba05f60c635d42f14bb8d79bff17c | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.19e-05 | 197 | 161 | 6 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 198 | 161 | 6 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-B_cells|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.42e-05 | 198 | 161 | 6 | 6231c44a909dd06f85c8210814e976a5f29148d0 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.42e-05 | 198 | 161 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 199 | 161 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-05 | 199 | 161 | 6 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | dfdfad881c114e1bc9a64b411e1b00fb37cc859b | |
| ToppCell | cellseq-Epithelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.90e-05 | 200 | 161 | 6 | e4204c4b864346f47d76b0f0faae96f04fed5082 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.90e-05 | 200 | 161 | 6 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | bfbd2ccf4b28901aad63d70a382a8247e4458ba6 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 67 | 161 | 4 | b80bdd122a0284611161c40ec7a9c893dc8de4de | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 152 | 161 | 5 | fa03262e2853b7d35ef8cdbb652930abad90563c | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 156 | 161 | 5 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 156 | 161 | 5 | 6f8622716bad4e505f241a2a4ef953bf3fc6dbfa | |
| Computational | ROS metabolism. | 3.00e-05 | 22 | 90 | 4 | MODULE_310 | |
| Computational | Genes in the cancer module 101. | 6.53e-05 | 10 | 90 | 3 | MODULE_101 | |
| Computational | Genes in the cancer module 132. | 1.93e-04 | 14 | 90 | 3 | MODULE_132 | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 1.46e-06 | 197 | 161 | 10 | 2788_DN | |
| Drug | glucosiduronate | 3.70e-06 | 171 | 161 | 9 | CID000000610 | |
| Drug | EUK-189 | 4.10e-06 | 16 | 161 | 4 | ctd:C436526 | |
| Drug | Clch2cosg | 6.82e-06 | 18 | 161 | 4 | CID000163913 | |
| Drug | C14791 | 6.82e-06 | 18 | 161 | 4 | CID011954044 | |
| Drug | C14793 | 6.82e-06 | 18 | 161 | 4 | CID011954046 | |
| Drug | C14803 | 6.82e-06 | 18 | 161 | 4 | CID011954054 | |
| Drug | C14805 | 6.82e-06 | 18 | 161 | 4 | CID011954056 | |
| Drug | C14804 | 6.82e-06 | 18 | 161 | 4 | CID011954055 | |
| Drug | C14806 | 6.82e-06 | 18 | 161 | 4 | CID011954057 | |
| Drug | C14848 | 6.82e-06 | 18 | 161 | 4 | CID011954067 | |
| Drug | C14856 | 6.82e-06 | 18 | 161 | 4 | CID011954069 | |
| Drug | C14855 | 6.82e-06 | 18 | 161 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 6.82e-06 | 18 | 161 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 6.82e-06 | 18 | 161 | 4 | CID000188517 | |
| Drug | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | 6.83e-06 | 6 | 161 | 3 | ctd:C042630 | |
| Drug | DNCB | 8.35e-06 | 189 | 161 | 9 | CID000000006 | |
| Drug | Ethoxyquin | 8.95e-06 | 40 | 161 | 5 | ctd:D005015 | |
| Drug | PX-866 | 1.07e-05 | 20 | 161 | 4 | CID009849735 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 1.07e-05 | 20 | 161 | 4 | CID011954072 | |
| Drug | C14865 | 1.07e-05 | 20 | 161 | 4 | CID011954073 | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A | 1.31e-05 | 200 | 161 | 9 | 3584_UP | |
| Drug | 2,4,6-trinitrotoluene | 1.53e-05 | 75 | 161 | 6 | CID000008376 | |
| Drug | S-(formylmethyl)glutathione | 2.29e-05 | 24 | 161 | 4 | CID011954074 | |
| Drug | tallow | CYP8B1 TTC27 MCM6 ITGB2 GSTM1 GSTM2 GSTM4 PIGA SCARA5 TM7SF2 | 2.35e-05 | 270 | 161 | 10 | ctd:C013698 |
| Drug | phenanthroline | 2.72e-05 | 50 | 161 | 5 | CID000067473 | |
| Drug | AC1Q608X | 4.32e-05 | 28 | 161 | 4 | CID000128466 | |
| Drug | AC1L33DC | 4.32e-05 | 28 | 161 | 4 | CID000133757 | |
| Drug | S-hexylglutathione | 4.34e-05 | 55 | 161 | 5 | CID000005140 | |
| Drug | Glutathione S-(2,4 Dinitrobenzene) | 4.97e-05 | 2 | 161 | 2 | DB02458 | |
| Drug | bromoacetylcholamine | 4.97e-05 | 2 | 161 | 2 | CID000192097 | |
| Drug | WHI P180 | 4.97e-05 | 2 | 161 | 2 | ctd:C118361 | |
| Drug | 2-BHA | 4.98e-05 | 29 | 161 | 4 | CID000006932 | |
| Drug | Dcvg | 6.53e-05 | 31 | 161 | 4 | CID006437359 | |
| Drug | o-dinitrobenzene | 6.53e-05 | 31 | 161 | 4 | CID000010707 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 7.16e-05 | 193 | 161 | 8 | 1048_DN | |
| Drug | PenCB | 7.18e-05 | 61 | 161 | 5 | CID000036188 | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.43e-05 | 194 | 161 | 8 | 7457_DN | |
| Drug | rosiglitazone maleate; Down 200; 10uM; PC3; HG-U133A | 7.43e-05 | 194 | 161 | 8 | 430_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 3723_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 2231_DN | |
| Drug | sulfobromophthalein | 9.25e-05 | 103 | 161 | 6 | CID000005345 | |
| Drug | m-toluidine | 9.47e-05 | 34 | 161 | 4 | CID000007934 | |
| Drug | Lyndiol | 9.47e-05 | 34 | 161 | 4 | CID000082149 | |
| Drug | UDP-N-acetylglucosamine | 1.02e-04 | 203 | 161 | 8 | CID000001167 | |
| Drug | dimethoxystrychnine | 1.06e-04 | 35 | 161 | 4 | CID000009649 | |
| Drug | Dixan | 1.06e-04 | 35 | 161 | 4 | CID000010404 | |
| Drug | Glutathione | 1.19e-04 | 36 | 161 | 4 | DB00143 | |
| Drug | methoxycarbonylmethyl disulfide | 1.48e-04 | 3 | 161 | 2 | CID003016930 | |
| Drug | 2-acetamidoethanethiol | 1.48e-04 | 3 | 161 | 2 | ctd:C023704 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 3.74e-09 | 5 | 156 | 4 | DOID:0050451 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.92e-06 | 195 | 156 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 2.78e-05 | 2 | 156 | 2 | OBA_2041806 | |
| Disease | 3,7-dimethylurate measurement | 2.78e-05 | 2 | 156 | 2 | EFO_0800949 | |
| Disease | iduronate 2-sulfatase measurement | 2.78e-05 | 2 | 156 | 2 | EFO_0020461 | |
| Disease | nicotine dependence (implicated_via_orthology) | 3.08e-05 | 12 | 156 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Degenerative Diseases, Central Nervous System | 5.35e-05 | 39 | 156 | 4 | C0270715 | |
| Disease | Neurodegenerative Disorders | 5.35e-05 | 39 | 156 | 4 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 5.35e-05 | 39 | 156 | 4 | C0751733 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.63e-04 | 152 | 156 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | T-cell non-Hodgkin lymphoma (is_implicated_in) | 1.65e-04 | 4 | 156 | 2 | DOID:0081312 (is_implicated_in) | |
| Disease | lifestyle measurement | 2.65e-04 | 235 | 156 | 7 | EFO_0010724 | |
| Disease | glutathione S-transferase Mu 1 measurement | 2.75e-04 | 5 | 156 | 2 | EFO_0801638 | |
| Disease | glucagon measurement, glucose tolerance test | 4.11e-04 | 6 | 156 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | acute promyelocytic leukemia (is_marker_for) | 4.11e-04 | 6 | 156 | 2 | DOID:0060318 (is_marker_for) | |
| Disease | epididymis-specific alpha-mannosidase measurement | 5.73e-04 | 7 | 156 | 2 | EFO_0801577 | |
| Disease | Head and Neck Neoplasms | 7.04e-04 | 33 | 156 | 3 | C0018671 | |
| Disease | Chloracne | 7.04e-04 | 33 | 156 | 3 | C0263454 | |
| Disease | cathepsin Z measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0008074 | |
| Disease | acid sphingomyelinase-like phosphodiesterase 3a measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0008013 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 8.26e-04 | 137 | 156 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 9.11e-04 | 36 | 156 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | N-acylethanolamine-hydrolyzing acid amidase measurement | 9.76e-04 | 9 | 156 | 2 | EFO_0008240 | |
| Disease | protein CREG1 measurement | 9.76e-04 | 9 | 156 | 2 | EFO_0801937 | |
| Disease | cathepsin F measurement | 9.76e-04 | 9 | 156 | 2 | EFO_0022038 | |
| Disease | Seizures | 1.10e-03 | 218 | 156 | 6 | C0036572 | |
| Disease | Congenital myasthenic syndrome | 1.22e-03 | 10 | 156 | 2 | cv:C0751882 | |
| Disease | Head and Neck Carcinoma | 1.22e-03 | 10 | 156 | 2 | C3887461 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.22e-03 | 10 | 156 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Lymphoma | 1.24e-03 | 40 | 156 | 3 | C0024299 | |
| Disease | gallbladder neoplasm | 1.48e-03 | 11 | 156 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 1.48e-03 | 11 | 156 | 2 | C0153452 | |
| Disease | Malignant Head and Neck Neoplasm | 1.64e-03 | 44 | 156 | 3 | C0278996 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.64e-03 | 44 | 156 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 1.75e-03 | 45 | 156 | 3 | C0278701 | |
| Disease | B-Cell Lymphomas | 1.77e-03 | 12 | 156 | 2 | C0079731 | |
| Disease | myeloid leukemia (is_implicated_in) | 2.08e-03 | 13 | 156 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 2.23e-03 | 49 | 156 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | platelet component distribution width | DOCK8 ABCC5 ATG14 VPS9D1 GSE1 EGFR EXOC3L4 PPP1R16B MACF1 CLINT1 HERC1 | 2.33e-03 | 755 | 156 | 11 | EFO_0007984 |
| Disease | median neuropathy (biomarker_via_orthology) | 2.42e-03 | 14 | 156 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.42e-03 | 14 | 156 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.69e-03 | 447 | 156 | 8 | C3714756 | |
| Disease | IGFBP-3 measurement | 2.95e-03 | 54 | 156 | 3 | EFO_0004626 | |
| Disease | leukemia | 3.11e-03 | 55 | 156 | 3 | C0023418 | |
| Disease | Dermatitis | 3.17e-03 | 16 | 156 | 2 | C0011603 | |
| Disease | Drug habituation | 3.30e-03 | 115 | 156 | 4 | C0013170 | |
| Disease | Drug abuse | 3.30e-03 | 115 | 156 | 4 | C0013146 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 3.30e-03 | 115 | 156 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | Prescription Drug Abuse | 3.30e-03 | 115 | 156 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.30e-03 | 115 | 156 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.30e-03 | 115 | 156 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.30e-03 | 115 | 156 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.30e-03 | 115 | 156 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.40e-03 | 116 | 156 | 4 | C0740858 | |
| Disease | colorectal cancer (is_implicated_in) | 3.96e-03 | 121 | 156 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | X-11470 measurement | 4.48e-03 | 19 | 156 | 2 | EFO_0021241 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 4.48e-03 | 19 | 156 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 4.48e-03 | 19 | 156 | 2 | DOID:2876 (is_marker_for) | |
| Disease | transitional cell carcinoma (is_marker_for) | 4.56e-03 | 63 | 156 | 3 | DOID:2671 (is_marker_for) | |
| Disease | Tinnitus | 5.10e-03 | 130 | 156 | 4 | HP_0000360 | |
| Disease | Cardiomyopathies | 5.10e-03 | 130 | 156 | 4 | C0878544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IRLLEIQADYHRRSL | 236 | Q6ZT62 | |
| LIRSYPDIRRDHILA | 651 | Q17RC7 | |
| HYARLKTLRSLEATD | 1306 | P21860 | |
| TIRRTGLAALRHYLF | 126 | Q96FG2 | |
| RLLTDYRGHTAEILD | 391 | Q13685 | |
| ILHLSAIALDRYRAI | 111 | P30939 | |
| IDLRSHYERLANLRR | 181 | Q6ZNE5 | |
| CRRLEARHYSLSLTA | 1151 | Q14687 | |
| IYLLLDRSFRARALD | 306 | O00155 | |
| SRREHGYDAVVLLAL | 201 | Q5T2E6 | |
| HLDSYEQSTRRLRPA | 651 | O60706 | |
| FISRELLHLVTLRYS | 606 | Q6MZZ7 | |
| LLHLVTLRYSDSVGR | 611 | Q6MZZ7 | |
| ETYHRTRALRSLRKD | 66 | Q6PL18 | |
| YSHRLSELRLLFGAR | 126 | O75493 | |
| LDSYLSAGRVRLHRL | 136 | Q9H8S5 | |
| VHRLLAAALGYRERL | 711 | Q8IYB7 | |
| VYLRLRHIDGREESF | 396 | O14874 | |
| RLRVHLLAAEGLYDR | 321 | Q8TF44 | |
| SYLAERLSRDVVRHR | 56 | Q14156 | |
| IHLRRYNLRRSALEI | 1941 | Q6ZS30 | |
| YAALHHRILALRSRV | 501 | Q9H6Z4 | |
| HSDIVVLYARTLRAL | 336 | Q6PCD5 | |
| RHRARLDASRLLLYS | 916 | P52333 | |
| TTRLLCTHRTEYLER | 776 | Q5T3U5 | |
| DDLLLGDYRLHLRRS | 166 | C9J6K1 | |
| TNRRRLSELLRYHTS | 446 | P08238 | |
| YAIARRIVDLHSRIE | 546 | Q14566 | |
| VLFYRHLTRRDETLT | 356 | Q13478 | |
| YRRLSRQLVASRHPD | 151 | Q12891 | |
| SLIHARRTYRELRLL | 61 | Q15759 | |
| EKLERYHTAIRRSES | 406 | O00515 | |
| VSELSVLRRVSHRYI | 106 | Q96QS6 | |
| LSTLTHSIVRRRYLA | 21 | Q9BW71 | |
| RYLSLGEHDRKRLED | 1351 | Q8WXG6 | |
| RVVTSAREHIYDLRS | 96 | Q14677 | |
| ILRYRDTIDFHLLTA | 451 | Q8NCT3 | |
| NEELRYSLRSIERHA | 326 | Q3T906 | |
| HGLFLRYRVEALTLR | 306 | O43292 | |
| VVAYERLAHVRARLA | 961 | Q4ZG55 | |
| RGLAHAIRLLLEYTD | 11 | P46439 | |
| DHPALYRDLLRTSRV | 296 | O75648 | |
| RLAHYIDRVRALELE | 56 | Q03252 | |
| VHRRYSALREESAKL | 531 | O75335 | |
| EVSIHTVRARLRLLY | 4391 | Q15751 | |
| TVRARLRLLYHFSDL | 4396 | Q15751 | |
| TIRSFEGIRRYAHEL | 91 | P06126 | |
| LLASSAHGRLRRITY | 16 | Q14766 | |
| IRHTEERLLRYLIHL | 1011 | Q32MH5 | |
| ERLLRYLIHLRFQSS | 1016 | Q32MH5 | |
| RGLAHSIRLLLEYTD | 11 | P28161 | |
| LHRLSTPRLYEADRS | 1101 | Q8WXX7 | |
| VRERSYQRALLLSDH | 1261 | Q8IZD2 | |
| ISLLNSERYARLERA | 1891 | O94854 | |
| SHKELYERARELLVS | 261 | Q9Y4W2 | |
| YRDHRLTMLLRESLA | 676 | Q9ULI4 | |
| LTLHRYRDAASRRAL | 56 | Q92616 | |
| LRTHCYRAALETVIR | 336 | Q96FB5 | |
| ELVGRHYFLELRRLS | 306 | Q9BRR3 | |
| DRHVAVSDRLRYSAI | 121 | O95006 | |
| LLRYFLEHLRVSALV | 946 | Q8NDA8 | |
| RERNLHVSLLDRLYE | 836 | P42694 | |
| LIRGHYEVRASRLEL | 86 | A8MYZ5 | |
| RLGSAALDSVHEYRL | 771 | Q6ZV29 | |
| EVIRIRATALTRHAY | 746 | Q7Z442 | |
| LLYFTALLVHREARD | 376 | O76062 | |
| YLTRRRRIEIAHTLC | 161 | P09629 | |
| RRYGHALRLTAVVLA | 276 | Q96RI0 | |
| HSVILLACRIRYERD | 166 | Q8WXB1 | |
| YLRAAELLLDHGVRV | 241 | Q96T49 | |
| RRRDHISHFILRLAY | 96 | P49643 | |
| LIHLSDLREYRRFEK | 726 | P05107 | |
| LRASSRLHDELFRRI | 941 | O15440 | |
| LSRPALLVRAARHYE | 661 | Q8N0W3 | |
| LASHLRFDRAELERL | 126 | Q96A11 | |
| VSVDRYLAVRHPLRS | 116 | O60755 | |
| NYLEDRRLVHRDLAA | 826 | P00533 | |
| YRTAHATRERIRVEA | 76 | Q02575 | |
| NEEHLRRSLRTILAY | 1566 | Q8NF50 | |
| DRLLLSEHYSRRISQ | 2951 | Q9H799 | |
| LHSYLSRLIAAERER | 161 | Q9UNE7 | |
| AESVGYLEISLRLHR | 61 | O75718 | |
| YLEISLRLHRLLRDS | 66 | O75718 | |
| VLFLFLLHRDVSSRE | 21 | Q8NCL4 | |
| RELTELDIYHRILRF | 201 | Q7Z3C6 | |
| AADVHARYIELLTRS | 996 | P15924 | |
| YIVDLLTHLTGRRAE | 181 | Q3B7J2 | |
| QLSSLELRRYFHRID | 156 | Q9P0W0 | |
| SRLDEEHRLIARYAA | 396 | O60941 | |
| EHRLIARYAARLAAE | 401 | O60941 | |
| ELTAREHLQLYTRLR | 2141 | Q9BZC7 | |
| LSRRHEELLVAYRAP | 306 | A2IDD5 | |
| SLFLTAIDRYISIHR | 206 | P21554 | |
| LYAALAALEEHRRVS | 366 | Q96SL8 | |
| AQADLRRVLLRLYHL | 906 | Q9Y2E5 | |
| SREVLYEIFRSLHTL | 26 | Q9NS73 | |
| RAVLSGLRHFTEYRI | 771 | P14616 | |
| SSNRLDEEHRLIARY | 426 | Q9Y4J8 | |
| DEEHRLIARYAARLA | 431 | Q9Y4J8 | |
| DDRHLTNRVLSLGYR | 316 | O00219 | |
| SLALLEEYVDRRLHR | 296 | Q9NT22 | |
| LYVRRAALAARSLLD | 1356 | Q9NYQ7 | |
| RLSLERDYHSLCERQ | 46 | P43250 | |
| RDSVYDLLRRVCTHL | 166 | Q8IUY3 | |
| YTLTNRDLRHALLRL | 306 | Q9H228 | |
| YDVALHRTRLQDLRV | 236 | Q6ZMJ2 | |
| RAEALYRLSLAQHLR | 776 | O00411 | |
| ALAARRHYSELVADR | 46 | P49448 | |
| RAAPTLLRLVHEDYT | 351 | Q9UNU6 | |
| ALDDRERRISHSLYS | 706 | Q8TEW0 | |
| ARVRAVTYHLEDLRR | 111 | Q0VD86 | |
| VLALRLYEHTEVFRR | 1376 | Q6ZRI0 | |
| RLAELRLAHNGDLRY | 111 | Q9GZU5 | |
| LHYRSARTKELDALL | 476 | O43196 | |
| IRLGYARISHAELSD | 621 | Q9H720 | |
| LTLSRRIRRAQLAHY | 651 | Q9BW92 | |
| RLHEEGIIYRSTRLV | 461 | P26640 | |
| SDRSVLYLHRSLADL | 46 | Q5TGL8 | |
| LRHYLRLEISESRVP | 146 | Q6ZMZ0 | |
| LVTSDLDHYLRREAL | 856 | Q96KN7 | |
| RTLVRDLHLSITDDY | 1511 | A6NHR9 | |
| HLERLAYLHARLREL | 456 | P78395 | |
| RYHFLEERLARSGLT | 411 | Q96I59 | |
| RGLAHAIRLLLEYTD | 11 | Q03013 | |
| SILRERFDRGLYASH | 466 | Q9Y227 | |
| RGLAHAIRLLLEYTD | 11 | P09488 | |
| SRRLRIALLYSHSEL | 136 | Q7Z3Z4 | |
| SYHRLREDVMRLSRL | 266 | Q9BY78 | |
| SRRALHRTLSDESIY | 1576 | O43166 | |
| VLLEAYARRLRHAIA | 416 | Q9BR26 | |
| LESIIRGLYHLARTE | 1346 | Q7Z745 | |
| HADYRRITRASALLD | 61 | O15524 | |
| HLDAARYINGRRETL | 261 | Q9H6W3 | |
| YFIDRESTLRRLHHI | 201 | Q9C0B6 | |
| RTDHRLYRDGTLKLL | 616 | Q9UNK9 | |
| ELRYRTIQLHRESAL | 416 | Q70JA7 | |
| TLLRHILVSDRYRFL | 136 | Q8NCH0 | |
| LHRRLVPTYESASIR | 546 | P28329 | |
| RLHKRFSALELERAY | 316 | Q9P2E5 | |
| RLSEELYHRCRLSNL | 736 | Q9P2E5 | |
| LSAAQLRRLEEHRYS | 21 | Q8WUD6 | |
| LRRLEEHRYSAAGVS | 26 | Q8WUD6 | |
| ERYQLHDRVRLLGAL | 276 | P37287 | |
| LKQHAYSEERRSARL | 206 | O14730 | |
| SLRHSRFRLDIYRCL | 206 | P48995 | |
| AEARETARRLLTHYV | 566 | Q9UID3 | |
| SLLHGYRSLIERDVS | 366 | Q9HA65 | |
| LYHSFARLGLRRAET | 651 | Q86Y38 | |
| AERSTERRLLGHLYN | 226 | A2A3L6 | |
| HVALRSRRDELHYLR | 231 | Q9Y5W7 | |
| SRRDELHYLRKLTEL | 236 | Q9Y5W7 | |
| SEAAHRLARRLYHLE | 311 | Q9BQI7 | |
| DGSRIREHELLYRIN | 861 | Q5TF21 | |
| ARYLEAALRLHRLLR | 56 | Q92791 | |
| AALRLHRLLRDSEAF | 61 | Q92791 | |
| ERAYTILRRHGLLFL | 961 | O00329 | |
| LYLSHLSRLRAAVAA | 491 | Q6ZSY5 | |
| YKASERRRHLSERLS | 6 | Q8NEG5 | |
| TAGLRDTHIYDARRL | 466 | Q9H967 | |
| DTHIYDARRLNSRRS | 471 | Q9H967 | |
| EVDSLRHSRSRLNIY | 186 | Q9UL62 | |
| ESRRRSIFEYHRIEL | 271 | Q8IUK5 | |
| LYRSVHRAREAALSR | 461 | Q9Y2B5 | |
| RLFVSVHLRRIESYS | 376 | Q96QU8 | |
| SEAIKAYHRLLDLRD | 646 | Q6P3X3 | |
| IHDRELSLYDGSRLL | 531 | A3KMH1 | |
| RVRYRLTAISVDHSA | 416 | Q8NFY4 | |
| NCRLLLREEATHIYR | 2171 | P01266 | |
| DVDSLRHSRSRLNIY | 186 | Q9UBN4 | |
| HDRIRQEDLRRLISY | 96 | O75962 | |
| LRFAYTSLLAIHRRI | 291 | A8K8V0 | |
| EVLLSETIRHFRLYS | 661 | Q9NX78 | |
| DSARRRSRAVLYHIS | 161 | Q96L42 | |
| ADREIYLLRTSLHRE | 556 | Q9C099 | |
| LDTLRLASSYIAHLR | 146 | O60682 | |
| RAHLERQRYLELRAA | 1086 | B2RTY4 |